Drugs for preventing malaria in pregnant women in endemic areas: Any drug regimen versus placebo or no treatment

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Radeva Petrova, Denitsa ^a   Kayentao, Kassoum ^a,b   ter Kuile, Feiko O ^a   Sinclair, David ^a   Garner, Paul ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b Sociétés   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; CHLOROQUINE; DAPSONE PLUS PYRIMETHAMINE; FOLIC ACID; HEMOGLOBIN; IRON; MEFLOQUINE; PLACEBO; PROGUANIL; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; RIBOFLAVIN;

AMNION BAND SYNDROME; ANEMIA; ANOPHTHALMIA; ANOREXIA; BRACHYDACTYLY; CONGENITAL MALFORMATION; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DOWN SYNDROME; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; EVIDENCE BASED MEDICINE; FETUS WASTAGE; FEVER; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INFANT MORTALITY; INFECTION PREVENTION; INTERMITTENT PREVENTIVE TREATMENT; KERNICTERUS; LOW BIRTH WEIGHT; MALARIA; MATERNAL MORTALITY; META ANALYSIS; MOUTH ULCER; MULTIDRUG RESISTANCE; NAUSEA; NAUSEA AND VOMITING; NEWBORN MORTALITY; PARASITEMIA; PATIENT COMPLIANCE; PERINATAL MORTALITY; PLASMODIUM VIVAX MALARIA; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK REDUCTION; SKIN MANIFESTATION; SLEEP DISORDER; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; TOE MALFORMATION; UNSPECIFIED SIDE EFFECT; VERTIGO; VISUAL IMPAIRMENT; VOMITING; WEAKNESS; FEMALE; MOSQUITO; NEWBORN; PREGNANCY COMPLICATIONS, PARASITIC; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIMALARIALS; FEMALE; HUMANS; INFANT, NEWBORN; MALARIA; MOSQUITO CONTROL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84921976926     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000169.pub3     Document Type: Review

References (92)

1. Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergström S. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Tropical Medicine and International Health 2004;9(10):1066-73.
2. Cot M, Roisin A, Barro D, Yada A, Verhave J, Carnevale P, et al. Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: results of a randomized trial. American Journal of Tropical Medicine and Hygiene 1992;46(1):21-7.
3. Cot M, Le Hesran JY, Miailhes P, Esveld M, Etya'ale D, Breart G. Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: results of a randomized trial in Cameroon. American Journal of Tropical Medicine and Hygiene 1995;53(6):581-5.
4. Fleming AF, Briggs ND, Rossiter CE. Growth during pregnancy in Nigerian teenage primigravidae. British Journal of Obstetrics and Gynaecology 1985;92(Suppl 5):32-9.
5. Fleming AF, Ghatoura GB, Harrison KA, Briggs ND, Dunn DT. The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. Annals of Tropical Medicine and Parasitology 1986;80(2):211-33.
6. Greenwood AM, Menendez C, Todd J, Greenwood BM. The distribution of birthweights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994;88(3):311-2.
7. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib-N'Jie AB. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 1989;83(5):589-94.
8. Menendez C, Todd J, Alonso P, Lulat S, Francis N, Greenwood BM. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. Journal of Tropical Medicine and Hygiene 1994;97(4):244-8.
9. Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, et al. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Tropical Medicine and International Health 2006;11(7):992-1002.
10. Menendez C, Todd J, Alonso PL, Lulat S, Francis N, Greenwood BM. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. Journal of Tropical Medicine and Hygiene 1994;97(4):244-8.
11. Menéndez C, Bardají A, Sigauque B, Romagosa C, Sanz S, Serra-Casas E, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008;3(4):e1934.
12. Menéndez C, Bardají A, Sigauque B, Sanz S, Aponte JJ, Mabunda S, Alonso PL. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS ONE 2010;5(2):e9438.
13. Morley D, Woodland M, Cuthbertson WF. Controlled trial of pyrimethamine in pregnant women in an African village. British Medical Journal 1964;1(5384):667-8.
14. Nahlen BL, Akintunde A, Alakija T, Nguyen-Dinh P, Ogunbode O, Edungbola LD, et al. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet 1989;2(8667):830-4.
15. Ndyomugyenyi R, Magnussen P. Chloroquine prophylaxis, iron-folic acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on maternal parasitaemia and haemoglobin levels and on birthweight. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000;94(4):413-8.
16. Ndyomugyenyi R, Magnussen P. Chloroquine prophylaxis, iron/folic-acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on congenital malaria and infant haemoglobin concentrations. Annals of Tropical Medicine and Parasitology 2000;94(8):759-70.
17. Ndyomugyenyi R, Clarke SE, Hutchison CL, Hansen KS, Magnussen P. Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 2011;105(11):607-16.
18. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003;97(3):277-82.
19. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003;97(3):277-82.
20. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, et al. Mefloquine prophylaxis in pregnancy: a double-blind placebo-controlled trial. Journal of Infectious Diseases 1994;169(3):595-603.
21. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene 1998;59(5):813-22.
22. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene 1998;59(5):813-22.
23. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999;353(9153):632-6.
24. Villegas L, McGready R, Htway M, Paw MK, Pimanpanarak M, Arunjerdja R, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Tropical Medicine and International Health 2007;12(2):209-18.
25. Asa OO, Onayade AA, Fatusi AO, Ijadunola KT, Abiona TC. Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women. Maternal and Child Health Journal 2008;12(6):692-8.
26. Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. Journal of Infectious Diseases 2009;200(6):991-1001.
27. Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. Journal of Infectious Diseases 2008;198(8):1202-11.
28. Deen JL, von Seidlein L, Pinder M, Walraven GEL, Greenwood BM. The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95(4):424-8.
29. Diakite OS, Kayentao K, Traoré BT, Djimde A, Traoré B, Diallo M, et al. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in Mali: a randomized controlled trial. Clinical Infectious Diseases 2011;53(3):215-23.
30. Diallo M, Dabo CAT, Saye R, Yattara O, Diarra MA, Kayentao K, et al. Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali [Essai clinique randomisé de deux schémas de préventioncontre le paludisme au cours de la grossesse à Faladiè (Mali)]. Médecine Tropicale 2007;67(5):477-80.
31. Dolan G, ter Kuile FO, Jacoutot V, White NJ, Luxemburger C, Malankirii L, et al. Bed nets for the prevention of malaria and anaemia in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993;87(6):620-6.
32. Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Journal of Infectious Diseases 2006;194(3):286-93.
33. Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: Impact on parasitaemia, anaemia and birth weight. Tropical Medicine and International Health 2009;14(2):174-82.
34. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Journal of Infectious Diseases 2007;196(11):1585-94.
35. Hamilton PJ, Gebbie DA, Wilks NE, Lothe F. The role of malaria, folic acid deficiency and haemoglobin AS in pregnancy at Mulago hospital. Transactions of the Royal Society of Tropical Medicine and Hygiene 1972;66(4):594-602.
36. Helitzer-Allen DL, Macheso A, Wirima J, Kendall C. Testing strategies to increase use of chloroquine chemoprophylaxis during pregnancy in Malawi. Acta Tropica 1994;58(3-4):255-66.
37. Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. Journal of Infectious Diseases 2005;191(1):109-16.
38. Luntamo M, Kulmala T, Cheung YB, Maleta K, Ashorn P. The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. Tropical Medicine and International Health 2013;18(4):386-97.
39. Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K, Ashorn P. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. American Journal of Tropical Medicine and Hygiene 2010;83(6):1212-20.
40. Luntamo M, Rantala A-M, Meshnick SR, Cheung YB, Kulmala T, Maleta K, et al. The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS One 2012;7(7):e41123.
41. Martin GE, Nkwate CC. Administration of a single monthly dose of 600 mg chloroquine base in the control of malaria in pregnant women [Administration de la dose unique mensuelle de 600 mg de chloroquine base dans le controle du paludisme chez les femmes enceintes]. CEAC Bulletin 1982;53:41-7.
42. McDermott JM, Heymann DL, Wirima JJ, Macheso AP, Wahl RD, Steketee RW, et al. Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitaemia and placental infection in pregnant women in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 1988;82(4):520-3.
43. McGready R, Hamilton KA, Simpson JA, Cho T, Luxemburger C, Edwards R, et al. Safety of the insect repellent N, N-diethyl-M-toluamide (DEET) in pregnancy. American Journal of Tropical Medicine and Hygiene 2001;65(4):285-9.
44. Menéndez C, Serra-Casas E, Scahill MD, Sanz S, Nhabomba A, Bardají A, et al. HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clinical Infectious Diseases 2011;52(1):41-8.
45. Mutabingwa T, Malle L, de Geus A, Oosting J. Malaria chemosuppression in pregnancy. I. The effect of chemosuppressive drugs on maternal parasitaemia. Tropical and Geographical Medicine 1991;45(1):6-14.
46. Naniche D, Lahuerta M, Bardaji A, Sigauque B, Romagosa C, Berenguera A, et al. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Medicine 2008;9(9):757-64.
47. Ouédraogo A, Bougouma EC, Diarra A, Konaté AT, Nébié I, Tiono AB, et al. Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso [Impact comparatif de trois schémas de prévention du paludismependant la grossesse sur l'anémie maternelle, associéeà l'infection palustre au Burkina Faso]. Médecine et maladies infectieuses 2008;38(4):180-6.
48. Tiono AB, Ouedraogo A, Bougouma EC, Diarra A, Konaté AT, Nébié I, et al. Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens. Malaria Journal 2009;8:224.
49. Pertet AM. Marital status and history of a previous child are risk factors in infant mortality. Social Science & Medicine 1994;38(11):1589.
50. Randriambelomanana JA, Rakotoarisoa H, Herinirina SA, Zafindravola BA, Andrianampanalinarivo HR. Comparison of efficacy of chloroquine versus sulfadoxine-pyrimethamine in malaria prevention in pregnant women in the Toamasina region (Madagascar) [Comparaison de l'efficacité de la chloroquine versus sulfadoxine-pyriméthamine dans la prévention du paludisme chez la femme enceintedans la région de Toamasina (Madagascar)]. Bulletin de la Société de Pathologie Exotique 2011;104(4):243-9.
51. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. American Journal of Tropical Medicine and Hygiene 1994;51(5):515-22.
52. Serra-Casas E, Menéndez C, Bardají A, Quintó L, Dobaño C, Sigauque B, et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. Journal of Infectious Diseases 2010;201(1):123-31.
53. Shulman CE, Dorman EK, Talisuna AO, Lowe BS, Nevill C, Snow RW, et al. A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on Kenyan coast. Tropical Medicine & International Health 1998;3(3):197-204.
54. Bloland P, Slutsker L, Steketee RW, Wirima JJ, Heymann DL, Breman JG. Rates and risk factors for mortality during the first two years of life in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):82-6.
55. Mangochi Malaria Research Project. Malaria prevention in pregnancy: the effects of treatment and chemoprophylaxis on placental malaria infection, low birth weight, and fetal, infant, and child survival. U.S. Agency for International Development in conjunction with Centers for Disease Control and Prevention, Atlanta, Ga; Africa Regional Project (698-0421) 1996.
56. McDermott JM, Slutsker L, Steketee RW, Wirima JJ, Breman JG, Heymann DL. Prospective assessment of mortality among a cohort of pregnant women in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):66-70.
57. McDermott JM, Wirima JJ, Steketee RW, Breman JG, Heymann DL. The effect of placental malaria infection on perinatal mortality in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):61-5.
58. Redd SC, Wirima JJ, Steketee RW, Breman JG, Heymann DL. Transplacental transmission of Plasmodium falciparum in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):57-60.
59. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):42-9.
60. Steketee RW, Wirima JJ, Campbell CC. Developing effective strategies for malaria prevention programs for pregnant African women. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):95-100.
61. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):33-41.
62. Steketee RW, Wirima JJ, Slutsker L, Breman JG, Heymann DL. Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):17-23.
63. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):50-6.
64. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, et al. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):24-32.
65. Steketee RW, Wirima JJ, Slutsker WL, Khoromana CO, Breman JG, Heymann DL. Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: The Mangochi Malaria Research Project. American Journal of Tropical Medicine and Hygiene 1996;55(Suppl 1):8-16.
66. Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One 2010;5(12):e14425.
67. Thaler J, Neugebauer J, Wolf J, Dakouré-Ouedraogo M, Köhler H, Wessel L, et al. Effects of riboflavin given to pregnant women on the incidence of malaria: Results of a prospective randomized double blind study [Auswirkungen einer prophylaktischen Gabe von Riboflavin an Schwangere auf die Häufigkeit der Malaria: Ergebnisse einer prospektiven randomisierten Studie]. Geburtshilfe und Frauenheilkunde 2006;66:383-90.
68. Tukur IU, Thacher TD, Sagay AS, Madaki JK. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. American Journal of Tropical Medicine and Hygiene 2007;76(6):1019-23.
69. Valea I, Tinto H, Drabo MK, Huybregts L, Henry MC, Roberfroid D, et al. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Malaria Journal 2010;9:324.
70. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile, FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Medicine 2010;7(1):e1000221.
71. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. The Lancet Infectious Diseases 2007;7(2):93-104.
72. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. The Lancet Infectious Diseases 2012;12(12):942-9.
73. Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-reated nets for preventing malaria in pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003755.pub2]
74. Higgins J, Green S (editors). Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions. Version 4.2.5 [updated May 2005]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 1 March 2006).
75. Higgins JPT Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2011.
76. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Journal of the American Medical Association 2013;309(6):594-604.
77. McClure EM, Goldenberg RL, Dent AE, Meshnick SR. A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. International Journal of Gynaecology and Obstetrics 2013;121(2):103-9.
78. Nkhoma ET, Bowman NM, Kalilani-Phiri L, Mwapasa V, Rogerson SJ, Meshnick SR. The effect of HIV infection on the risk, frequency, and intensity of Plasmodium falciparum parasitemia in primigravid and multigravid women in Malawi. American Journal of Tropical Medicine and Hygiene 2012;87(6):1022-7.
79. Nkhoma ET, Kalilani-Phiri L, Mwapasa V, Rogerson SJ, Meshnick SR. Effect of HIV infection and Plasmodium falciparum parasitemia on pregnancy outcomes in Malawi. American Journal of Tropical Medicine and Hygiene 2012b;87(1):29-34.
80. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
81. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. American Journal of Tropical Medicine and Hygiene 2001;64(1-2 Suppl):28-35.
82. ter Kuile FO, Parise ME, VerhoeffFH, Udhayakumar V, Newman RD, van Eijk AM, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. American Journal of Tropical Medicine and Hygiene 2004;71(2 Suppl):41-54.
83. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Journal of the American Medical Association 2007;297(23):2603-16.
84. White NJ. Intermittent presumptive treatment for malaria. PLoS Medicine 2005;2(1):e3.
85. World Health Organization. Guidelines for the treatment of malaria. 2nd Edition. Geneva: World Health Organization, 2010.
86. World Health Organization. World Malaria Report. World Health Organization, Geneva 2012.
87. World Health Organization. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). http://www.who.int/malaria/publications/atoz/policy_brief_iptp_sp_policy_recommendation/en/2013.
88. Garner P, Brabin B. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bulletin of the World Health Organization 1994;72(1):89-99.
89. Garner P. Routine antimalarial drug chemoprophylaxis during pregnancy in endemic malarious areas. Cochrane Database of Systematic Reviews 1995, Issue 1.
90. Garner P, Gulmezoglu AM. Prevention versus treatment for malaria in pregnant women. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000169]
91. Garner P, Gulmezoglu AM. Drugs for preventing malaria-related illness in pregnant women and death in the newborn. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000169]
92. Garner P, Gulmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD000169.pub2]